Aris Global
ArisGlobal is a life sciences software company that provides cloud-based platforms for pharmacovigilance, regulatory affairs, clinical development, and medical affairs. It serves pharmaceutical, biotech, and contract research organizations by automating drug safety and regulatory workflows to support compliance and product lifecycle management. The company generates revenue through subscriptions and services for its SaaS products and related implementation and support.
- Revenue
- $250M - $1B
- Employees
- 1,001 - 5,000
- Founded
- 1987
- Headquarters
- Chicago Loop, United States of America
Aris Global customers on Arbolus
Customers who reviewed Aris Global
Seniority of Aris Global customers
Most people who reviewed Aris Global hold Director roles (58%), followed by C-Suite (35%) and Manager (7%).
- Director 58%
- C-Suite 35%
- Manager 7%
Customers sample
Employer names and spend open in the full report, along with the other 39 customers.
What 42 Arbolus experts think of Aris Global
NPS scores are predominantly positive, with 40% of responses in the 8-10 range and several perfect 10s from high value users. Renewal intent trends similarly positive among larger spenders and long-term adopters, while dissent is more common among newer pilots or low spenders. Most users are in the more-than-a-year implementation stage (over 70%), signaling platform stickiness and critical workflow integration. Key expert feedback highlights efficiency in regulatory processes and scalable automation, but some cite challenges around cost and complexity. Positive
Everything 42 customers told us about Aris Global.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
23 Net Promoter Score, from 42 scored reviews- Promoters 17
- Passives 18
- Detractors 7
Praised
- Broader Digital Integrations
- Automation for Mid-Sized Organizations
- Streamlined Onboarding
- Streamlined Approvals and Communication
Criticised
- Legacy System Integration Risks
- Emergence of New Competitors
- Cost Pressure in Smaller Firms
- Complex Implementation for New Users
What Aris Global customers say
Streamlined Approvals and Communication
“I have used this tool across multiple pharma companies to speed up regulatory approvals by integrating digital tools that enable proactive communication.”
Scalable Across Company Sizes
“I’ve found this solution beneficial for both lean and large organizations, given its adaptability and regular incorporation into key processes.”
Integrated Digital Workflow
“Integration of this tool with digital workflows made it possible for me to achieve faster feedback and approvals in complex regulatory environments.”
Renewal intent
Plan to renew 54%Plan to renew, by seniority
- 27% 11 answers
- 64% 14 answers
- 100% 2 answers
- 100% 1 answer
- 8.5/10 Average score from customers who will renew
- 7/10 Average score from undecided customers
- 2.7/10 Average score from customers not renewing
Top alternatives
Most weighed by Aris Global customersReport
For people who use Aris Global
Do you use Aris Global at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 42 customers of Aris Global have already contributed
Takes a few minutes. Your identity stays anonymous.